Showing 1 - 20 results of 23 for search 'Roberta Maltoni', query time: 0.05s
Refine Results
-
1
-
2
-
3
-
4
-
5
-
6
An Italian Real-World Study Highlights the Importance of Some Clinicopathological Characteristics Useful in Identifying Metastatic Breast Cancer Patients Resistant to CDK4/6 Inhibi... by Roberta Maltoni, Andrea Roncadori, William Balzi, Massimiliano Mazza, Fabio Nicolini, Michela Palleschi, Paola Ulivi, Sara Bravaccini
Published 2024-02-01
Article -
7
Chronological age or biological age: What drives the choice of adjuvant treatment in elderly breast cancer patients? by Roberta Maltoni, Sara Ravaioli, Giuseppe Bronte, Massimiliano Mazza, Claudio Cerchione, Ilaria Massa, William Balzi, Michela Cortesi, Michele Zanoni, Sara Bravaccini
Published 2022-01-01
Article -
8
-
9
Appropriateness and Economic Analysis of Conventional Circulating Biomarkers Assessment in Early Breast Cancer: A Real-World Experience from the E.Pic.A Study by Roberta Maltoni, William Balzi, Tania Rossi, Francesco Fabbri, Sara Bravaccini, Maria Teresa Montella, Ilaria Massa, Lucia Bertoni, Fabio Falcini, Mattia Altini
Published 2022-01-01
Article -
10
Dissecting Molecular Heterogeneity of Circulating Tumor Cells (CTCs) from Metastatic Breast Cancer Patients through Copy Number Aberration (CNA) and Single Nucleotide Variant (SNV)... by Tania Rossi, Davide Angeli, Michela Tebaldi, Pietro Fici, Elisabetta Rossi, Andrea Rocca, Michela Palleschi, Roberta Maltoni, Giovanni Martinelli, Francesco Fabbri, Giulia Gallerani
Published 2022-08-01
Article -
11
Case Report: Analysis of Circulating Tumor Cells in a Triple Negative Spindle-Cell Metaplastic Breast Cancer Patient by Tania Rossi, Michela Palleschi, Davide Angeli, Michela Tebaldi, Giovanni Martinelli, Ivan Vannini, Maurizio Puccetti, Francesco Limarzi, Roberta Maltoni, Giulia Gallerani, Francesco Fabbri
Published 2021-06-01
Article -
12
Single-Cell NGS-Based Analysis of Copy Number Alterations Reveals New Insights in Circulating Tumor Cells Persistence in Early-Stage Breast Cancer by Tania Rossi, Giulia Gallerani, Davide Angeli, Claudia Cocchi, Erika Bandini, Pietro Fici, Michele Gaudio, Giovanni Martinelli, Andrea Rocca, Roberta Maltoni, Francesco Fabbri
Published 2020-09-01
Article -
13
The Expression of Programmed Death Ligand 1 and Vimentin in Resected Non-Metastatic Non-Small-Cell Lung Cancer: Interplay and Prognostic Effects by Sara Bravaccini, Giuseppe Bronte, Elisabetta Petracci, Maurizio Puccetti, Manolo D’Arcangelo, Sara Ravaioli, Maria Maddalena Tumedei, Roberta Maltoni, Angelo Delmonte, Federico Cappuzzo, Lucio Crinò
Published 2021-11-01
Article -
14
Why the complications of COVID-19 patients differ in elderly and young cancer patients by Sara Bravaccini, Fabio Nicolini, Michele Zanoni, Anna Gaimari, Claudio Cerchione, Roberta Maltoni, Francesca Pirini, Lucia Mazzotti, Michela Cortesi, Sara Ravaioli, Maria Maddalena Tumedei, Massimiliano Mazza
Published 2022-12-01
Article -
15
Computed tomography based analyses of body mass composition in HER2 positive metastatic breast cancer patients undergoing first line treatment with pertuzumab and trastuzumab by Michela Palleschi, Andrea Prochowski Iamurri, Emanuela Scarpi, Marita Mariotti, Roberta Maltoni, Francesca Mannozzi, Domenico Barone, Giovanni Paganelli, Michela Casi, Emanuela Giampalma, Ugo De Giorgi, Andrea Rocca
Published 2022-03-01
Article -
16
miR-9-5p as a Regulator of the Androgen Receptor Pathway in Breast Cancer Cell Lines by Erika Bandini, Francesca Fanini, Ivan Vannini, Tania Rossi, Meropi Plousiou, Maria Maddalena Tumedei, Francesco Limarzi, Roberta Maltoni, Francesco Fabbri, Silvana Hrelia, William C. S. Cho, Muller Fabbri
Published 2020-11-01
Article -
17
T-Cell Receptor Repertoire Sequencing and Its Applications: Focus on Infectious Diseases and Cancer by Lucia Mazzotti, Anna Gaimari, Sara Bravaccini, Roberta Maltoni, Claudio Cerchione, Manel Juan, Europa Azucena-Gonzalez Navarro, Anna Pasetto, Daniela Nascimento Silva, Valentina Ancarani, Vittorio Sambri, Luana Calabrò, Giovanni Martinelli, Massimiliano Mazza
Published 2022-08-01
Article -
18
Real-World Outcomes and Treatments Patterns Prior and after the Introduction of First-Line Immunotherapy for the Treatment of Metastatic Non-Small Cell Lung Cancer by Valentina Danesi, Ilaria Massa, Flavia Foca, Angelo Delmonte, Lucio Crinò, Giuseppe Bronte, Maria Ragonesi, Roberta Maltoni, Silvia Manunta, Paola Cravero, Kalliopi Andrikou, Ilaria Priano, William Balzi, Nicola Gentili, Thomas Burke, Mattia Altini
Published 2022-09-01
Article -
19
Androgen Receptor Expression in Breast Cancer: What Differences Between Primary Tumor and Metastases? by Giuseppe Bronte, Sara Bravaccini, Sara Ravaioli, Maurizio Puccetti, Emanuela Scarpi, Daniele Andreis, Maria Maddalena Tumedei, Samanta Sarti, Lorenzo Cecconetto, Elisabetta Pietri, Valeria De Simone, Roberta Maltoni, Massimiliano Bonafè, Dino Amadori, Andrea Rocca
Published 2018-08-01
Article -
20
Androgen receptor in advanced breast cancer: is it useful to predict the efficacy of anti-estrogen therapy? by Giuseppe Bronte, Andrea Rocca, Sara Ravaioli, Maurizio Puccetti, Maria Maddalena Tumedei, Emanuela Scarpi, Daniele Andreis, Roberta Maltoni, Samanta Sarti, Lorenzo Cecconetto, Anna Fedeli, Elisabetta Pietri, Valeria De Simone, Silvia Asioli, Dino Amadori, Sara Bravaccini
Published 2018-03-01
Article